U.S. Sen. Tammy Baldwin has introduced new legislation to create industry standards for regenerative medicine.The bill would create a public-private board to set guidelines for regenerative medical products, including those developed from stem cells. Dr. Bill Murphy, co-director of University of Wisconsin-Madison’s Stem Cell and Regenerative Medicine Center, said the standards used currently aren’t specific to the cells and tissues used in the therapies.